Hoth Therapeutics, Inc. — Investor Relations & Filings
Filings indexed
326
across all filing types
Latest filing
2026-05-28
Regulatory Filings
Country
US
United States of America
Listing
US
HOTH
Hoth Therapeutics, Inc. is a clinical-stage biopharmaceutical company that acts as a catalyst in early-stage pharmaceutical research and development. The company focuses on advancing promising drug candidates from discovery through pre-clinical and clinical testing to address unmet medical needs. Its development pipeline includes innovative therapeutics for conditions such as skin disorders. Guided by a patient-centric mission to improve quality of life, Hoth Therapeutics also utilizes artificial intelligence to support its drug development programs.
Recent filings
| Filing | Released | Lang | Actions |
|---|---|---|---|
| CURRENT REPORT | 2026-05-28 | English | |
| PROSPECTUS SUPPLEMENT | 2026-05-27 | English | |
| CURRENT REPORT | 2026-05-27 | English | |
| CURRENT REPORT | 2026-05-21 | English | |
| QUARTERLY REPORT | 2026-05-15 | English | |
| 8-K - Hoth Therapeutics, Inc. (0001711786) (Filer) | 2026-05-06 | English |
Browse filings by year
10 years| ID | Filing | Released | Lang | Actions | |
|---|---|---|---|---|---|
|
2026
13 filings
| |||||
| 47860174 | CURRENT REPORT | 2026-05-28 | English | ||
| 47846174 | PROSPECTUS SUPPLEMENT | 2026-05-27 | English | ||
| 47540654 | CURRENT REPORT | 2026-05-27 | English | ||
| 46753358 | CURRENT REPORT | 2026-05-21 | English | ||
| 46362293 | QUARTERLY REPORT | 2026-05-15 | English | ||
| 41998159 | 8-K - Hoth Therapeutics, Inc. (0001711786) (Filer) | 2026-05-06 | English | ||
| 41071328 | 8-K - Hoth Therapeutics, Inc. (0001711786) (Filer) | 2026-05-04 | English | ||
| 34650412 | 8-K - Hoth Therapeutics, Inc. (0001711786) (Filer) | 2026-04-16 | English | ||
| 34650389 | 424B5 - Hoth Therapeutics, Inc. (0001711786) (Filer) | 2026-04-16 | English | ||
| 33192520 | 8-K - Hoth Therapeutics, Inc. (0001711786) (Filer) | 2026-04-02 | English | ||
| 33180659 | 424B5 - Hoth Therapeutics, Inc. (0001711786) (Filer) | 2026-04-02 | English | ||
| 33066014 | 10-K - Hoth Therapeutics, Inc. (0001711786) (Filer) | 2026-03-27 | English | ||
| 13051071 | CURRENT REPORT | 2026-01-16 | English | ||
|
2025
2 filings
| |||||
| 13051074 | Regulatory Filings 2025 | 2025-12-05 | English | ||
| 13051075 | REGISTRATION STATEMENT | 2025-11-14 | English | ||
Market data
Market data not available
Last price
Market cap
volume
Day range
today
52-week range
trailing
Price history
Peer group · Research and experimental development on natural sciences and engineering
| Company | Ticker | Country | Sector |
|---|---|---|---|
|
Cardiol Therapeutics Inc.
Clinical-stage company developing anti-inflammatory therapi…
|
CRDL | CA | Professional, scientific and te… |
|
CASSAVA SCIENCES INC
Clinical-stage biotech developing treatments for Central Ne…
|
SAVA | US | Professional, scientific and te… |
|
Celcuity Inc.
Clinical-stage biotech developing targeted therapies for mu…
|
CELC | US | Professional, scientific and te… |
|
Cell Bio Human Tech Co., Ltd
Develops and manufactures cellulose-based nonwoven fabrics …
|
318160 | KR | Professional, scientific and te… |
|
CEL SCI CORP
Clinical-stage biotech developing immunotherapies for cance…
|
CVM | US | Professional, scientific and te… |
|
Celyad Oncology SA
Biotechnology company developing innovative CAR-T cell ther…
|
CYAD | BE | Professional, scientific and te… |
|
Ceres Power Holdings PLC
A developer of solid oxide technology for clean power and g…
|
CWR | GB | Professional, scientific and te… |
|
Certara, Inc.
Accelerates drug development using biosimulation software, …
|
CERT | US | Professional, scientific and te… |
|
CervoMed Inc.
A clinical-stage biotech developing treatments for age-rela…
|
CRVO | US | Professional, scientific and te… |
|
Chabiotech Co.,Ltd.
Develops cell/gene therapies and provides CDMO and bio-bank…
|
085660 | KR | Professional, scientific and te… |
Hoth Therapeutics, Inc. via the API
Pull this company's filings, identifiers, and metadata as JSON or Markdown. Authenticate with your API key, then query by company ID, ISIN, or LEI. Full schema documented in the OpenAPI spec.
Endpoints
| GET | /api/companies/34935/ | Company identity, sector, listing, identifiers |
| GET | /api/filings/?company=34935 | Paginated list of all filings (filterable by type, date, language) |
| GET | /api/filings/{id}/ | Single filing — metadata, document URL, processing status |
| GET | /api/filings/{id}/markdown/ | Filing content as Markdown (PDF → text/tables/figures) |
| GET | /api/isins/?company=34935 | All ISINs registered to this company |
| GET | /api/filing-types/ | Reference: every filing-type code + category |
Full reference: API reference · OpenAPI schema
cURL
$ curl https://api.financialreports.eu/api/filings/?company=34935 \ -H "x-api-key: $FR_API_KEY" \ -H "Accept: application/json"
Python
import requests r = requests.get( "https://api.financialreports.eu/api/filings/", params={"company": 34935}, headers={"x-api-key": API_KEY}, ) filings = r.json()["results"]
MCP server
// MCP server URL https://mcp.financialfilings.com/mcp // Once connected, the LLM can query this company directly: "Pull the latest 5 filings for Hoth Therapeutics, Inc. (id: 34935)"
Report missing filing
Can't find a specific document? Let us know and we'll add it within 24 hours.
We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.